Document is current
Any future updates will be listed below
-
Authors
Wu, Yan https://orcid.org/0000-0003-2596-1943
Hao, Chenzhou
Gao, Chao https://orcid.org/0000-0003-3662-6518
Hageman, Matt
Lee, Sungmoo
Kirkland, Thomas A. https://orcid.org/0000-0003-0859-5785
Gray, Nathanael S. https://orcid.org/0000-0001-5354-7403
Su, Yichi https://orcid.org/0000-0001-5715-835X
Lin, Michael Z. https://orcid.org/0000-0002-0492-1961
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R21NS122055)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (1R21DA048252)
SU | School of Medicine, Stanford University
SU | Stanford Bio-X
- License Information
-
More Information
Article History
Received: 18 April 2024
Accepted: 20 January 2025
First Online: 11 February 2025
Competing interests
: Y.S., M.Z.L. and Y.W. are coinventors on a patent application describing the KiMBI method (patent applicant: the board of trustees of the Leland Stanford Junior University; names of inventors: Y.S., M.Z.L. and Y.W.; application number: PCT/US2023/074363; publication number: WO2024059832A1). C.G., M.H. and T.A.K. are employees of Promega Corporation. The other authors declare no competing interests.
